SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
|
|
- Oscar Kennedy
- 5 years ago
- Views:
Transcription
1 SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician ASWCN TAUNTON AND SOMERSET Taunton Lung MDT (11-2C-1) /12 Dr Sarah Foster Compliance Self Assessment LUNG MDT 85.2% (23/27) Key Themes Structure and function of the service The Taunton and Somerset NHS Foundation Trust Lung Cancer Multidisciplinary Team is a multi-professional group serving Taunton and the surrounding area in the Somerset Primary Care Trust, a population of over 340,000. It is part of the Avon Somerset and Wiltshire Cancer Network (ASWCS). The lead clinician is a Consultant Respiratory Physician, supported by three other consultant respiratory colleagues. The lead clinician leads the clinical activity of the team, working to agreed guidelines, ensuring we provide a high quality, integrated service which meets local, regional and national standards. All the key core members are in place with cross cover available: - consultant respiratory physician - thoracic surgeon - clinical oncologist - imaging specialist - histopathologist - lung clinical nurse specialist - MDT co-ordinator - palliative care nurse specialist Extended members of the team include: - clinical trials nurses - nurse counsellor - bereavement officer The lung clinical nurse specialist has responsibility for user issues. Cross cover is provided for SELF ASSESSMENT REPORT for Taunton - Lung MDT (published: 30th September 2011) Page: 1/6
2 her by the palliative care nurse specialists and vice versa. The team meets weekly on a Thursday lunchtime. A list of patients to be discussed at the meeting is held on the Somerset Cancer Register and is e mailed on the Wednesday to all core MDT members by the MDT coordinator. Urgent cases arising in the twenty four hours preceding the meeting are discussed and added to the Somerset Cancer Registrar at the meeting. We also videolink with the Yeovil Lung multi disciplinary team to facilitate communication, team working and discuss shared cases. We provide thorocoscopy diagnostic service to the Yeovil lung MDT. Where a patient with lung cancer is deemed to require an urgent treatment planning decision that needs to be made prior to the next scheduled lung cancer MDT meeting, the following procedure is in place: - Telephone discussion with the relevant treating consultant or their cross cover - Formal written letter to follow telephone discussion as a permanent record - The case will be discussed at the next scheduled MDT meeting The lung multi disciplinary team has benefited from having a stable core team with good communication. In the last year, it has benefited from the appointment of a fourth Consultant Respiratory Physician and increased thoracic surgical input. This has been achieved following the appointment of a new Consultant Thoracic Surgeon at Bristol and via the videolink to Yeovil. The Lung MDT meets annually to discuss operational matters, audit data and service improvement matters. The team are proactive in ensuring sufficient clinic space is available to accomodate two week wait patients and achieved 98% compliance with the 2 week wait standard in With the 31 day and 62 day targets, achievement was 100% and 85% compliance respectively. A breakdown of age and sex profile of the patients treated by the team can be found in the annual report. The Somerset Cancer Register does not currently hold data on ethnicity. This data is collected on other electronic patient systems and the Trust is looking to integrate with these so that we will be able to assess this fully in the future. The ethnicity profile of the local area is predominantly White British so this is not something the team or Trust has prioritised to date. Coordination of care/patient pathways The lung cancer multidisciplinary team aims to ensure a coordinated approach to diagnosis, treatment and care services for all patients with lung cancer and mesothelioma. The Lung MDT is committed to achieving the highest standards of care and patient outcomes by: - Working to agreed NSSG guidance - Collection of high quality data - Analysis of such data in audit cycles - Involvement in local, national and international research studies - Incorporation of new research and best practice into patient care SELF ASSESSMENT REPORT for Taunton - Lung MDT (published: 30th September 2011) Page: 2/6
3 - Referral of patients to the ASWCS Network Mesothelioma MDT - Providing comprehensive information to patients and their relatives - Involving patients in assessment and redesign of the services Patients with suspected lung cancer are referred by their GP to the Consultant Chest Physicians via the 2-week wait referral system. The referrals and CXR are screened by one of the four consultants, if cancer is considered likely on the basis of the initial referral and CXR, a CT scan is arranged. An out-patient appointment is offered by telephone -- if this is not acceptable to the patient, a second offer is made within the 2-week time frame. The consultants' secretaries arrange the outpatient appointments. Urgent slots are available in all four consultants clinics. The team work proactively to achieve compliance with the 2 week wait standard. Imaging investigations are arranged through the Radiology department with alternative dates suggested where necessary. The patient is seen in outpatients in the Somerset Lung Centre at the hospital or in a peripheral clinic. Lung function testing is performed at the appointment and arrangements are made to obtain a histological diagnosis via bronchoscopy, radiologically guided biopsy or thoracoscopy as necessary. There are four bronchoscopy lists available each week, with also the facility to perform medical thoracoscopy. All patients are offered a follow up appointment to receive results either in person or via telephone, dependent upon patient choice. All patients are allocated a key worker, which is usually the lung cancer nurse specialist but can be any core team member. All patients are given the contact details of the nurse specialist and she runs an open access outpatient clinic once weekly. Where a patient is given a diagnosis of lung cancer, the patient's GP is informed by the end of the next working day. This policy applies both to in-patients and out-patients. This measure is the subject of regular audit. All relevant members of the MDT offer patients a permanent record of consultations at which treatment options are discussed. All treatment decisions are recorded on the Somerset Cancer Register. The team adhere to the Network guidelines and NICE guidance for the diagnosis and management of lung cancer. We aim to ensure there is at least one member of team present at the Network lung SSG meetings. In the last year, a further two core team members have attended the advanced communication skills training. Patient experience The team aim to be accessible to patients and carers. They encourage patient feedback, both formal and informal. The National Patient Experience Survey 2010 provided the team with feedback relating to their performance. On the whole, patients and carers were very happy with the way they were treated throughout the patient pathway. They felt they were provided with plenty of information and were able to SELF ASSESSMENT REPORT for Taunton - Lung MDT (published: 30th September 2011) Page: 3/6
4 ask questions. This has been conveyed to the team. There were mixed experiences in relation to PET scans but hopefully this should improve with the weekly PET scan provision in Taunton by Inhealth. One patient raised an issue around the place of delivery of diagnosis. The team aim to ensure diagnosis is delivered in a quiet, private place, with next of kin present if the patient wishes and specialist nurse if possible. With only one lung cancer nurse specialist, the team acknowledge that this may not always be achievable. There was also some disparity around written records of patient consultations. These are now given as a matter of course, unless the patient requests otherwise. Patients and carers can also be directed to the Cancer Information Centre within the hospital and the counselling service. Clinical outcomes/indicators Lung Clinical Lines of Enquiry Data for the Taunton and Somerset Lung MDT 2010 from the National Lung Cancer Audit 2010 (Lucada data): 1. Percentage of expected cases of whom data is collected - 149% 2. The percentage histological confirmation rate % 3. The percentage having active treatment % 4. The percentage undergoing surgical resection (excluding mesothelioma and confirmed small cell lung cancer) % 5. The percentage of small cell cancer patients receiving chemotherapy - 80% Histological confirmation rate - the national average rate is 76%. Our lower than the national average figure is most likely a combination of data entry and patients being only fit for palliative or supportive care on presentation. Lung Cancer is unfortunately often detected late in people with other medical co-morbidities. We are looking at our accuracy of data entry to ensure this is not a contributing factor and working with our data entry people to improve this measure. Our percentage of patients receiving active treatment is above the national average of 59%. The surgical resection rate is above the national average of 13.9% and has improved with weekly thoracic surgical input to our mdt either in person or via videolink. This is also demonstrated in our recent audit of surgical resection. Our percentage of patients receiving chemotherapy for small cell lung cancer is in line with the national average. A consultant physician takes the lead for integration of research and recruitment to clinical trials. He is supported by the clinical trials nurses. Since July 2009, we have recruited 54 patients to TIME1. We have recruited 2 patients to SWAMP and 21 to Fragmatic. We have just opened TIME3 in taunton and have recruited our first patient. SELF ASSESSMENT REPORT for Taunton - Lung MDT (published: 30th September 2011) Page: 4/6
5 The team completed the last network audit of oncology treatment related admissions and are collecting data for the current audit of clinical nurse specialist presence when a patient is informed of a lung cancer diagnosis. Good Practice Good Practice/Significant Achievements - Good compliance with cancer wait time standards - Videolink of MDT to Yeovil to facilitate cross county working - Increased thoracic surgical input via core member attendance or their cross cover and videolink to Yeovil - Recruitment to clinical trials - Positive feedback from the National Patient Experience Survey Team attendance at SSG Concerns Immediate Risks Serious Concerns Concerns Key team challenges: 1. To improve our histological diagnosis rate This is being addressed by ensuring our data input is accurate by working with our MDT coordinator and assistant. The team do acknowledge however that a proportion of patients will only be fit for palliative or supportive care on presentation and therefore would not be suitable to pursue a histological diagnosis. Lung cancer is unfortunately often detected late in people with other medical co-morbidities. 2. The team currently only has one lung cancer nurse specialist. SELF ASSESSMENT REPORT for Taunton - Lung MDT (published: 30th September 2011) Page: 5/6
6 General Comments The Lung MDT has a well established team which works well together and communicates effectively with its tertiary centre and the Cancer Network. Organisational Statement I, Sarah Foster (Lead Clinician) on behalf of TAUNTON AND SOMERSET agree this is an honest and accurate assessment of the Lung MDT. SELF ASSESSMENT REPORT for Taunton - Lung MDT (published: 30th September 2011) Page: 6/6
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician GMCN ROYAL WOLVERHAMPTON HOSPITALS The Royal Wolverhampton Hospitals Trust Lung MDT (11-2C-1) - 2011/12 Dr Angela Morgan
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician NECN NORTH TEES AND HARTLEPOOL North Tees And Hartlepool Lung MDT (11-2C-1) - 2011/12 Dr D N Leitch Compliance Self
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT NECN N Tees & Hartlepool North Tees And Hartlepool Date Self Assessment Completed 23rd July 2009 Date of IV Review 19th June 2009
More informationLCA Lung Clinical Forum. 21 st October 2014
LCA Lung Clinical Forum 21 st October 2014 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA Commissioning Intentions for
More informationPEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)
PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM) Network Organisation (Trust) Team DCN POOLE Poole THYROID ONLY MDT (11-2I-2) - 2011/12 Peer Review Visit Date 18th August 2011 Compliance THYROID ONLY
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician CSCCN PORTSMOUTH HOSPITALS Portsmouth Colorectal MDT (11-2D-1) - 2011/12 Daniel OLeary Compliance Self Assessment COLORECTAL
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MVCN EAST AND NORTH HERTFORDSHIRE Mount Vernon Cancer Centre Cancer Network MDT (11-2K-1) - 2011/12 Date Self Assessment Completed
More informationNational Optimal Lung Cancer Pathway
National Optimal Lung Cancer Pathway This document was produced by the Lung Clinical Expert Group 2017 Document Title: National Optimal Lung Cancer Pathway and Implementation Guide Date of issue: August
More informationACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report
ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY Phases One and Two Final Report July 2017 Introduction This paper presents the learning and actions that have been generated from phase One and Two
More informationDelivering 62 Day GP Cancer Waits in a Complex Landscape. Hannah Marder Cancer Manager University Hospitals Bristol
Delivering 62 Day GP Cancer Waits in a Complex Landscape Hannah Marder Cancer Manager University Hospitals Bristol Overview The 62 day GP target Cancer pathways What causes breaches? Good practice and
More informationNational Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer
National Optimal Lung Cancer Pathways Dr Sadia Anwar ttingham University Hospitals NHS Trust Clinical Lead for Lung Cancer Overview How NOLCP evolved How it relates to national guidance Pathways Implementation
More informationNational Cancer Peer Review Programme
National Cancer Peer Review Programme Julia Hill Acting Deputy National Co-ordinator What is Cancer Peer Review? A quality assurance process for cancer services. An integral part of Improving Outcomes
More informationNICE Quality Standards and COF
NICE Quality Standards and COF David Baldwin Consultant Respiratory Physician NUH Hon Senior Lecturer Nottingham University Clinical lead NICE lung cancer GL Chair NICE QS Topic Expert Group Quality Standards
More informationQuality Standards for Diagnosis and Treatment in Breast Units Across Greater Manchester
Quality Standards for Diagnosis and Treatment in Breast Units Across Greater Manchester Greater Manchester Cancer Clinical Director: Mr Mohammed Absar Pathway Manager: Rebecca Price Pathway approval: 24
More informationLung cancer timed clinical pathways
Lung cancer timed clinical pathways December 2017 1 Context This document sets out best practice timed clinical pathways for lung cancer. It is anticipated that all Cancer Alliances will audit against
More informationa. Clarity is gained regarding the urgency level attached to each referral with clear guidance issued to both primary care and the community teams.
Collated Action Plan in Response to the Recommendations made in the Report of a Review in Respect of Mr K and the provision of Mental Services following a Homicide committed in March 2011 Recommendation
More informationNational Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator
National Cancer Peer Review Sarcoma Julia Hill Acting Deputy National Co-ordinator Improving Outcomes Guidance The Intentions of Improving Outcomes for People with Sarcoma Changes in the provision of care
More informationImproving services for upper GI (OG) cancer Application template (Version 2)
Trust Clinical lead Improving services for upper GI (OG) cancer Application template (Version 2) Managerial lead Date completed 14 June 2013 Barnet & Chase Farm Hospitals NHS Trust Dr Marta Carpani Upper
More informationGuideline for the Management of Patients Suitable for Immediate Breast Reconstruction
Version History Guideline for the Management of Patients Suitable for Immediate Breast Reconstruction Version Summary of change Date Issued 2.0 Endorsed by the Governance Committee 20.02.08 2.1 Circulated
More informationSERVICE SPECIFICATION 6 Conservative Management & End of Life Care
SERVICE SPECIFICATION 6 Conservative Management & End of Life Care Table of Contents Page 1 Key Messages 2 2 Introduction & Background 2 3 Relevant Guidelines & Standards 2 4 Scope of Service 3 5 Interdependencies
More informationSingle Suspected Cancer Pathway Definitions pathway start date
Single Suspected Cancer Pathway Definitions pathway start date Date: March 2018 Version: 1.2.1 Wales Cancer Owner: Network and Welsh Government Status Published 1 P a g e Purpose of Document This document
More informationNational Standards for Sarcoma Services
National Standards for Sarcoma Services 2009 TABLE OF CONTENTS 1. INTRODUCTION TO THE NATIONAL CANCER STANDARDS...2 2. METHODOLOGY...4 3. FORMAT...4 4. INTRODUCTION TO SARCOMA...5 STANDARDS TOPIC: ORGANISATION...10
More informationNational Standards for Sarcoma Services 2009
National Standards for Sarcoma Services 2009 Crown copyright July 2010 F1101011 Contents 1. Introduction to the National Cancer Standards 2. Methodology 3. Format 4. Introduction to Sarcoma Standards Topic:
More informationCancer Improvement Plan Update. September 2014
Cancer Improvement Plan Update September 2014 1 Contents Page 1. Introduction 3 2. Key Achievements 4-5 3. Update on Independent Review Recommendations 6-13 4. Update on IST Recommendations 14-15 5. Update
More informationAmbulatory lung biopsy: a new model for the NHS. Dr Sam Hare Barnet Hospital Royal Free London NHS Trust
Ambulatory lung biopsy: a new model for the NHS Dr Sam Hare Barnet Hospital Royal Free London NHS Trust Lung cancer Leading cause of UK cancer mortality UK: 2 nd lowest European survival rate 62-day RTT
More informationNational Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
More informationA06/S(HSS)b Ex-vivo partial nephrectomy service (Adult)
A06/S(HSS)b 2013/14 NHS STANDARD CONTRACT FOR EX-VIVO PARTIAL NEPHRECTOMY SERVICE (ADULT) PARTICULARS, SCHEDULE 2 THE SERVICES, A - SERVICE SPECIFICATION Service Specification No. Service Commissioner
More informationSkull Base Tumour Service. The Multi-Disciplinary Team (MDT) Explained. Jan 2018 v1
Skull Base Tumour Service The Multi-Disciplinary Team (MDT) Explained Jan 2018 v1 Skull base tumours grow in the bones of the skull that form the bottom of the head and the body ridge between the nose
More informationThere are a number of national guidelines and performance standards which support the implementation of a straight to CT pathway.
December 2015 CONTENTS Contents... 2 1 Introduction... 3 2 Case for Change... 3 3 Evidence... 3 3.1 National and regional policy... 3 3.2 Local audit... 4 4 Supporting Work Initiatives... 5 4.1 Identification
More informationCancer of Unknown Primary (CUP) Protocol
1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date
More information2010 National Audit of Dementia (Care in General Hospitals)
Royal College of Psychiatrists 2010 National Audit of Dementia (Care in General Hospitals) Organisational checklist results and commentary for: Barking, Havering and Redbridge Hospitals NHS Trust The 2010
More informationRuth Howkins Deputy National Coordinator National Cancer Peer Review
Ruth Howkins Deputy National Coordinator National Cancer Peer Review Purpose of Peer Review To ensure services are as safe as possible To improve the quality and effectiveness of care To improve the patient
More informationA Best Practice Clinical Care Pathway for Major Amputation Surgery
A Best Practice Clinical Care Pathway for Major Amputation Surgery April 2016 Introduction The perioperative mortality rate after major lower limb amputation in the UK is unacceptably high in modern medical
More informationActivity Report March 2012 February 2013
Lung Cancer Managed Clinical Network Activity Report March 2012 February 2013 John McPhelim Lead Lung Cancer Nurse MCN Clinical Lead Kevin Campbell Network Manager CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW
ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW Health Board: Named Health Board contact: Cancer Network: Named contact for Cancer Network: Health Inspectorate Wales contact: Abertawe Bro Morgannwg University
More informationIntegrated Cancer Services Action Plan. Colchester Hospital University NHS Foundation Trust 31 March 2014
Integrated Cancer Services Action Plan Colchester Hospital University NHS Foundation Trust 31 March KEY Implemented, clearly evidenced and externally approved On Track to deliver Some issues narrative
More informationAnnual Report Lung MDT
Annual Report Lung MDT University Hospitals Bristol NHS Foundation Trust 0117 923 0000 Minicom 0117 934 9869 www.uhbristol.nhs.uk Agreement and Approval Lung MDT Lead Clinician Adam Dangoor Date 27/09/2012
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More informationImproving Outcomes for People with Sarcoma
NHS National Institute for Health and Clinical Excellence Guidance on Cancer Services Improving Outcomes for People with Sarcoma List of All Recommendations March 2006 Developed for NICE by the National
More informationINTERNAL VALIDATION REPORT...
INTERNAL VALIDATION REPORT... Network Trust Team AngCN CAMBRIDGE UNIVERSITY HOSPITALS Addenbrookes Sarcoma Locality Measures (11-1D-1l) - 2011/12 Date Self Assessment Completed 30th November 2011 Date
More informationOperational Policy. Bristol Supra-Regional Testicular Cancer MDT
Operational Policy Bristol Supra-Regional Testicular Cancer MDT University Hospitals Bristol NHS Foundation Trust 0117 923 0000 Minicom 0117 934 9869 www.uhbristol.nhs.uk Agreement to Operational Policy
More informationWest Midlands Sarcoma Advisory Group
West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Sarcoma Specialist Multi Disciplinary Team for Suspected Sarcoma of Soft Tissue Extremities (limbs and trunk
More informationCancer Services Position & Recovery Plan June 2015
Appendix 6 Cancer Services Position & Recovery Plan June 2015 Introduction The Trust is required to achieve 85% compliance for patients on a 62 day pathway from the referral date to the date they receive
More informationGynae Cancer Multi Disciplinary Team Patient Information
Gynae Cancer Multi Disciplinary Team Patient Information Introduction This booklet is for people who have been diagnosed with gynaecological cancers which include cancer of the cervix, ovary, vulva, vagina
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Cancer of Unknown Primary Network Site Specific Group. Clinical Guidelines
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Cancer of Unknown Primary Network Site Specific Group Revision due: April 2019 Page 1 of 11 VERSION CONTROL THIS IS A CONTROLLED DOCUMENT.
More informationWork Programme/Service Delivery Plan 2010/2013
Essex and East Suffolk Gynaecological Cancer Network Site Specific Group Work Programme/Service Delivery Plan 2010/2013 Version Number 1.2 Author Members of the NSSG Date Written June 2010 Reviewed May
More informationCancer of Unknown Primary Service
Cancer of Unknown Primary Service Dr Maurice Fernando Consultant In Specialist Palliative Care and CUP lead Doncaster and Bassetlaw Hospitals NHS FT Wakefield meeting -14-07-2016 CUP service CUP MDT
More informationNational Peer Review Report: Wales Paediatric Diabetes 2014
National Peer Review Report: Wales Paediatric Diabetes 2014 An overview of the findings from the 2014 National Peer Review of Paediatric Diabetes Services in Wales 1 Contents 1.0 Introduction... 3 1.1
More informationSouth West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services
SWAG Cancer of Unknown Primary (CUP) Referral Processes The SWAG network site specific groups refer any patient with metastatic carcinoma of unknown origin on for discussion to the specialist carcinoma
More informationTable 1 Standards and items to set up a PCU: general requirements and critical mass
Table 1 Standards and items to set up a PCU: general requirements and critical mass General requirements and European Prostate Cancer Units are structures managing sufficient volumes of patients with on-site
More informationRecommendations from the Devon Prisons Health Needs Assessment. HMP Exeter, HMP Channings Wood and HMP Dartmoor
from the Devon Prisons Health Needs Assessment HMP Exeter, HMP Channings Wood and HMP Dartmoor 2011-2012 In April 2006 the responsibility for prison healthcare transferred from HM Prison Service to the
More informationWest Midlands Sarcoma Advisory Group
West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Specialist Sarcoma Multi Disciplinary Team for Suspected Bone Sarcoma Version History Version Date Brief Summary
More informationA. Service Specifications
SCHEDULE 2 THE SERVICES A. Service Specifications Service Specification No: 170050S Service Primary Ciliary Dyskinesia Management Service (adults) Commissioner Lead Provider Lead 1. Scope 1.1 Prescribed
More informationWorking with you to make Highland the healthy place to be
Highland NHS Board 2 June 2009 Item 4.3 BREAST CANCER SERVICES COMPLIANCE AGAINST 31 AND 62 DAY TARGETS Report by Derick MacRae, Cancer Service Manager on behalf of Dr Ian Bashford, Medical Director The
More informationSouth West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation
Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance Peninsula Cancer Alliance South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation Peninsula Thoracic-Oncology
More informationA. Service Specification
A. Service Specification Service Specification No: 1767 Service Adult Highly Specialist Pain Management Services Commissioner Lead For local completion Lead For local completion 1. Scope 1.1 Prescribed
More informationTest and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire
Test and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire Introduction This document introduces South Gloucestershire Clinical Commissioning
More information1. The Initial Referral Protocol (09-7A-113)
1. The Initial Referral Protocol (09-7A-113) REFERRAL PATHWAY: ONCOLOGY AND MALIGNANT HAEMATOLOGY SERVICE SHEFFIELD CHILDRENS NHS FOUNDATION TRUST This document contains information on how to access the
More informationDESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for
DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for 2008-11 1. Aims, Outcomes and Outputs The National Service Framework Designed to Tackle Renal Disease in Wales sets standards
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT DATE OF MEETING: 20th September 2012 TITLE OF REPORT: KEY MESSAGES: NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of its six strategic clinical
More information2010 National Audit of Dementia (Care in General Hospitals) North West London Hospitals NHS Trust
Royal College of Psychiatrists 2010 National Audit of Dementia (Care in General Hospitals) Organisational checklist results and commentary for: rth West London Hospitals NHS Trust The 2010 national audit
More informationShared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs Lung /chest wall sarcomas incl. pulmonary metastatectomy Version 2
Shared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs Lung /chest wall sarcomas incl. pulmonary metastatectomy Version 2 Background Sarcomas that arise in the lung de novo are
More informationGuidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer
Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group
More informationCancer of Unknown Primary (CUP)
Cancer of Unknown Primary (CUP) Information for patients This information is for people with cancer of unknown primary (CUP) and covers symptoms, investigations/tests and treatment options. If there is
More informationThe Virtual Lung Nodule Clinic
The Virtual Lung Nodule Clinic Poster No.: C-1023 Congress: ECR 2016 Type: Educational Exhibit Authors: S. Higgins, F. C. Lyall, J. Taylor, J. goldman, S. Rolin, B. 1 2 1 2 2 3 2 2 3 Soar ; Torbay/UK,
More informationNational Standards for Acute Oncology Services
Cancer National Specialist Advisory Group National Standards for Acute Oncology Services June 2016 TABLE OF CONTENTS 1. PURPOSE... 2 2. INTRODUCTION... 2 3. STRATEGIC CONTEXT... 4 4. SCOPE OF ACUTE ONCOLOGY
More informationBladder Cancer Guidelines
Bladder Cancer Guidelines Agreed by Urology CSG: October 2011 Review Date: September 2013 Bladder Cancer 1. Referral Guidelines The following patients should be considered as potentially having bladder
More informationHow can we facilitate cross-boundary working in Greater Manchester?
How can we facilitate cross-boundary working in Greater Manchester? Emma Halkyard Nurse Clinician Cross boundary working: where are we now? Our patients are complex Our pathways are complex Our treatments
More informationPathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer
NICaN Pathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer Timed schedules to enable the proactive management of the patient from point of receipt of referral to first definitive treatment
More informationSTANDARDS FOR UPPER GI CANCERS 2004
STANDARDS FOR UPPER GI CANCERS 2004 Source: CSCG Title: UPPER GI CANCERS STANDARDS Version: 10/CONSULTATION Page 1 of 33 1. INTRODUCTION TO THE CANCER STANDARDS 1.1 These Cancer Standards replace the previous
More informationScottish Parliament Region: North East Scotland. Case : Tayside NHS Board. Summary of Investigation
Scottish Parliament Region: North East Scotland Case 201104213: Tayside NHS Board Summary of Investigation Category Health: General Surgical; communication Overview The complainant (Mrs C) raised concerns
More information2010 National Audit of Dementia (Care in General Hospitals) Chelsea and Westminster Hospital NHS Foundation Trust
Royal College of Psychiatrists 2010 National Audit of Dementia (Care in General Hospitals) Organisational checklist results and commentary for: NHS Foundation Trust The 2010 national audit of dementia
More information2012/13 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL)
E10d 2012/13 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL) SECTION B PART 1 - SERVICE SPECIFICATIONS Service Specification No.
More information2010 National Audit of Dementia (Care in General Hospitals) Guy's and St Thomas' NHS Foundation Trust
Royal College of Psychiatrists 2010 National Audit of Dementia (Care in General Hospitals) Organisational checklist results and commentary for: Guy's and St Thomas' NHS Foundation Trust The 2010 national
More informationBriefing Paper. Single Cancer Pathway
Briefing Paper Single Cancer Pathway Author: Tom Crosby, Clinical Director, Wales Cancer Network Owner: Wales Cancer Network Date: 27 th November 2017 Version: 1.0 Publication/ Distribution: Wales Cancer
More informationHaemato-oncology Clinical Forum. 20 th June 2013
Haemato-oncology Clinical Forum 20 th June 2013 Welcome Dr Majid Kazmi, LCA Haemato-oncology Pathway Group Chair Purpose of today Provide an update on progress of the LCA to date Identify priorities for
More informationThe Ayrshire Hospice
Strategy 2010-2015 Welcome... The Ayrshire Hospice : Strategy 2010-2015 Index 05 06 08 09 10 12 15 17 19 Foreword Our vision and purpose Our guiding principles Our achievements 1989-2010 Our priorities
More informationAppendix 4 Urology Care Pathways
Appendix 4 Urology Care Pathways Cancer Care Pathways outline the steps and stages in the patient journey from referral through to diagnostics, staging, treatment, follow up, rehabilitation and if applicable
More informationManual for Cancer Services 2008: Northern Ireland - Colorectal Measures
National Cancer Action Team National Cancer Peer Review Programme Manual for Cancer Services 2008: Northern Ireland - Colorectal Measures NORTHERN IRELAND - COLORECTAL MEASURES GATEWAY No. XXXX - JUN 2009
More informationSAFE PAEDIATRIC NEUROSURGERY A Report from the SOCIETY OF BRITISH NEUROLOGICAL SURGEONS
SAFE PAEDIATRIC NEUROSURGERY 2001 A Report from the SOCIETY OF BRITISH NEUROLOGICAL SURGEONS SAFE PAEDIATRIC NEUROSURGERY 2001 INTRODUCTION In 1997 the SBNS agreed to the setting up of a task force to
More informationOne Stop Prostate Biopsy Protocol Author Consultation Date Approved
One Stop Prostate Biopsy Protocol Author Consultation Date Approved Urology Nurse Practioner PROTOCOL FOR MEN ATTENDING A ONE STOP PROSTATE BIOPSY CLINIC RATIONALE Prostate cancer is the most common cancer
More informationFRAILTY PATIENT FOCUS GROUP
FRAILTY PATIENT FOCUS GROUP Community House, Bromley 28 November 2016-10am to 12noon In attendance: 7 Patient and Healthwatch representatives: 4 CCG representatives: Dr Ruchira Paranjape went through the
More informationArrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist
Arrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist LOTS!!! This presentation confines itself to the situation in the North West. The views expressed are my
More informationCancer Access Policy. Key Points
Trust Policy Cancer Access Policy Key Points The timescales within which cancer patients are treated is a vital quality measure and key indicator of the quality of cancer services offered at the Trust.
More information02/GMS/0030 ADULT EPILEPSY SERVICE CCP for General Medical and Surgical POOLE HOSPITAL NHS FOUNDATION TRUST
Service Specification No. Service Commissioner Leads 02/GMS/0030 ADULT EPILEPSY SERVICE CCP for General Medical and Surgical Provider Lead POOLE HOSPITAL NHS FOUNDATION TRUST Period 1 April 2013 to 31
More informationDeveloping Services for Teenagers and Young Adults (TYA) with Cancer
Selena Riggs South West Specialised Commissioning Group Deirdre Brunton- Teenage Cancer Trust, TYA Lead Nurse Developing Services for Teenagers and Young Adults (TYA) with Cancer South West Specialised
More informationNATIONAL REHABILITATION HOSPITAL SPINAL CORD SYSTEM OF CARE (SCSC) OUTPATIENT SCOPE OF SERVICE
NATIONAL REHABILITATION HOSPITAL SPINAL CORD SYSTEM OF CARE (SCSC) OUTPATIENT SCOPE OF SERVICE Introduction: The Spinal Cord System of Care (SCSC) at the National Rehabilitation Hospital (NRH) provides
More informationACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW
ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW Health Board: Named Health Board contact: Cancer Network: Named contact for Cancer Network: Health Inspectorate Wales contact: Abertawe Bro Morgannwg University
More informationSingle Suspected Cancer Pathway Definitions pathway start date
Single Suspected Cancer Pathway Definitions pathway start date Date: December 2018 Version: 8.0 Wales Cancer Owner: Network and Welsh Government Status Draft 1 P a g e Purpose of Document This document
More informationBreast Cancer Multi Disciplinary Team Patient Information
Breast Cancer Multi Disciplinary Team Patient Information Introduction This booklet is for people who have been diagnosed with breast cancer. It tells you about the breast multidisciplinary team and other
More informationA Suite of Enhanced Services for. Prudent Structured Care for Adults with Type 2 Diabetes
An Enhanced Service for Prudent Structured Care for Adults with Type 2 Diabetes Page 1 A Suite of Enhanced Services for Prudent Structured Care for Adults with Type 2 Diabetes 1. Introduction All practices
More informationActivity Report March 2013 February 2014
West of Scotland Cancer Network Skin Cancer Managed Clinical Network Activity Report March 2013 February 2014 Dr Girish Gupta Consultant Dermatologist MCN Clinical Lead Tom Kane MCN Manager West of Scotland
More informationFreedom of Information Act Request Physiotherapy Services for Neurological Conditions
Freedom of Information Act Request Physiotherapy Services for Neurological Conditions 1. In total how many physiotherapists does C&V UHB employ? s services 33 qualified paediatric physiotherapy staff in
More informationActivity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2013 March 2014 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationPEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)
PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM) Regional Trauma Network Trauma Centre Trauma Service RMTN Network Organisation Measures (T13-1C-1) - 2013/14 Peer Review Visit Date 29th April 2014 Compliance
More informationThe Peninsula Network Site Specific Group for Thoracic Oncology
The Peninsula Network Site Specific Group for Thoracic Oncology Network Annual Report June 205 Acting Chair: Liz Toy Date Approved: Annual report of the Network Site Specific Group for Thoracic Oncology
More informationActivity Report April 2012 March 2013
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2012 March 2013 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationBREAST IMPLANT SURGERY INDIVIDUAL FUNDING REQUEST POLICY
BREAST IMPLANT SURGERY INDIVIDUAL FUNDING REQUEST POLICY Version: Recommendation by: 1617.V2b Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 13 July 2016 Name of Originator/Author:
More informationProject Initiation Document:
Project Initiation Document: Lancashire Support Services for Children, Young People, Families and Carers Affected by Autistic Spectrum Disorder (ASD) and Diagnosis 1. Background The Children and Young
More information